Sexual harassment complaints: 2 FIRs registered against Wrestling Federation of India chief, 1 of them under Pocso
Coronavirus situation under control in Delhi, not terrible, says Kejriwal
Maruti reports 54% YoY decline in sales in June; sells less than 40% of pre-coronavirus level
Government Bans 59 Chinese Apps Including Tik-Tok, Shareit, UC Browser, and WeChat
PM Modi to address the nation at 4 pm: What to expect
Maharashtra Extends Lockdown Till July 31 Day After Urging Caution
Coronavirus Vaccine Update
Swarms Of Desert Locusts Reach Delhi Outskirts After Gurugram
Delhi fighting difficult battle against COVID-19, will emerge victorious: Kejriwal
2-Week Lockdown In Guwahati From Monday; Minister Says "Shop By Sunday"
YouTube likely to come up with TikTok-like short video platform
Rs 2,000 crore from PM CARES Fund to be spent on 50,0000 ventilators for COVID-19 patients
Baba Ramdev's Patanjali launches India's 'first Ayurvedic' medicine for coronavirus, Coronil
Coronavirus: Glenmark conducts Fabiflu trial on 1,000 patients; to compete with Gilead's Remdesivir
Jio's golden touch makes Reliance Industries share rise 108% in 3 months
Coronavirus vaccine: When will it be ready? Moderna, AstraZeneca offer answers
Chennai lockdown starts today: Check what is allowed, not allowed
Coronavirus vaccine: Singapore scientists discover 5 antibodies that can combat COVID-19
India-China tension: Indian Army releases list of 20 martyrs; wreath ceremony begins in Leh
Tamil Nadu announces 'maximised restricted lockdown' from June 19 in Chennai, 3 other districts

Latest Posts

Coronavirus Vaccine Update

latest news update

The race for a coronavirus vaccine is continuing at break neck pace as cases mount across the world.

According to the World Health Organisation (WHO), there are 16 vaccine candidates currently in late-stage clinical trials among the 140 vaccines in different stages of development to fight COVID-19.

Of these 16 vaccine candidates, five are being researched in China, three in the US, two in the UK, and one each in Australia, Germany, and Russia.

But the big question is how far away is coronavirus vaccine? And what's the status of trials?

While many scientists and researchers anticipate that a safe and effective vaccine may take 12-18 months to develop, several others believe that if a medicine is formulated before the end of the year, it would be the fastest vaccine development in the world.

With the news of the Oxford University-AstraZeneca vaccine in its last-stage trial, the world is hopeful of an earlier than expected arrival of a COVID-19 vaccine.

Here are the latest developments on COVID-19 vaccine trials:-

1. Oxford University-AstraZeneca vaccine

According to the latest reports, the Oxford University-AstraZeneca vaccine candidate has emerged as a frontrunner in the race to find an effective cure for coronavirus. The British drugmaker has already started conducting phase III human trials of its AZD1222 (formerly known as ChAdOx1 nCoV-19) vaccine candidate. Around 800 people will be administered the vaccine. The developers have inked a deal to manufacture 10 crore doses of the vaccine. Brazil announced on Saturday that it had signed a $127 million deal to locally produce the Oxford-AstraZeneca vaccine.

2. Moderna coronavirus vaccine

American biotech company Moderna, which has begun phase II trials for its vaccine candidate mRNA-1273, has collaborated with drugmaker Catalent Inc to manufacture 100 million doses starting in the third quarter of 2020. Final-stage trials of the Moderna vaccine are all set to begin in July, with tests slated to be conducted on 30,000 people.

3. CanSino vaccine

China's military has received greenlight to use a COVID-19 vaccine candidate developed by its research unit and CanSino Biologics after clinical trials proved it was safe and somewhat efficient, the company said on Monday. The Ad5-nCoV is one of the eight vaccine candidates being developed by Chinese companies and researchers approved to be moved into human trials. The shot also won approval for human testing in Canada. China's Central Military Commission approved the use of the vaccine by the military on June 25 for a period of one year, CanSino said in a filing. The vaccine candidate was developed jointly by CanSino and the Beijing Institute of Biotechnology in the Academy of Military Medical Sciences.

4. Sanofi-GSK coronavirus vaccine

French pharma major Sanofi, which has developed a COVID-19 vaccine candidate with GlaxoSmithKline (GSK), recently announced that it plans to start phase 1 of its clinical trial by the end of the year. If the first stage results turnout to be positive, the company will also get the approval for mass production in the second half of 2021. Sanofi is using one of GSK's proprietary additives, a compound that drives the immune response, with this vaccine. The French drugmaker plans to manufacture 10 crore doses in 2020 and another 100 crore in 2021.

Sanofi also announced that it will invest $425 million in US start-up Translate Bio to broaden its vaccine development venture.

5. BNTECH-Pfizer vaccine

German company BNTECH has tied up with US-based drugmaker Pfizer for developing a COVID-19 vaccine. Their vaccine candidate is based on messenger RNA technology, similar to Moderna. Tests for the same are being conducted on volunteers in Germany and the US. The vaccine is in phase one of its clinical trials with the first set of results likely in the coming weeks. Pfizer expects to start commercial production of vaccine by October 2020.

6. Novavax vaccine

American vaccine development company Novavax is carrying out human trials of its protein-based NVX-CoV2373 candidate vaccine in Australia. The results are expected by July. Novavax plans to manufacture 10 crore doses by this year and 150 crore in 2021.


Alert Message

Please Wait...

Share the Opinion Poll with your Friends At


Share the Survey with your
Friends At